Pharmacy News

Hospira Recalls Lactated Ringer's and 5% Dextrose Injection

Cheryl A. Thompson

BETHESDA, MD 28 Jan 2013—Injectable drug maker Hospira Inc. on January 25 announced the recallExternal Link of lot 05-019-JT of lactated Ringer's and 5% dextrose injection because a customer found a particulate consistent with mold in one of the 1000-mL flexible containers.

The company said the bags in this lot had been distributed between June 2011 and January 2012 to wholesalers, hospitals, and pharmacies across the country.

Anyone with a bag of lactated Ringer's and 5% dextrose injection from lot 05-019-JT is being instructed to quarantine it immediately and call Stericycle at 888-965-5798 between 8 a.m. and 5 p.m. EST, Monday through Friday, to arrange for the return of the product.

Hospira said it is working to determine the root cause of the sterility problem.

As of Friday, the company had not identified any quality-related issues in its samples from lot 05-019-JT.

The company said replacement product from other lots is available.


Contact Us
For questions, comments, or more information on this article, please contact the ASHP News Center at
ASHP Product Listing